ANTIMETABOLITES 116
MARKET SIZE 117
TABLE 73 GLOBAL SALES OF ANTIMETABOLITES TO TREAT LIVER DISEASES, BY REGION, THROUGH 2014 ($ MILLIONS) 117
FIGURE 39 GLOBAL SALES OF ANTIMETABOLITES TO TREAT LIVER DISEASES, BY REGION, 2007-2014 ($ MILLIONS) 117
ANABOLIC STEROIDS 118
MARKET SIZE 118
TABLE 74 GLOBAL SALES OF ANABOLIC STEROIDS TO TREAT LIVER DISEASES, BY REGION, THROUGH 2014 ($ MILLIONS) 118
FIGURE 40 GLOBAL SALES OF ANABOLIC STEROIDS TO TREAT LIVER DISEASES, BY REGION, 2007-2014 ($ MILLIONS) 119
ALCOHOL ABUSE DRUGS 119
MARKET SIZE 119
TABLE 75 GLOBAL SALES OF ALCOHOL ABUSE DRUGS, BY REGION, THROUGH 2014 ($ MILLIONS) 120
FIGURE 41 GLOBAL SALES OF ALCOHOL ABUSE DRUGS, BY REGION, 2007-2014 ($ MILLIONS) 120
ANTI-REJECTION MEDICATION 120
MARKET SIZE 121
TABLE 76 GLOBAL SALES OF ANTI-REJECTION MEDICATION TO TREAT LIVER DISEASES, BY REGION, THROUGH 2014 ($ MILLIONS) 121
FIGURE 42 GLOBAL SALES OF ANTI-REJECTION MEDICATION TO TREAT LIVER DISEASES, BY REGION, 2007-2014 ($ MILLIONS) 121
INFECTION-FIGHTING DRUGS 122
MARKET SIZE 122
TABLE 77 GLOBAL SALES OF INFECTION-FIGHTING DRUGS TO TREAT LIVER TRANSPLANT PATIENTS, BY REGION, THROUGH 2014 ($ MILLIONS) 122
FIGURE 43 GLOBAL SALES OF INFECTION-FIGHTING DRUGS TO TREAT LIVER TRANSPLANT PATIENTS, BY REGION, 2007-2014 ($ MILLIONS) 123
ANTIFUNGAL PROPHYLAXIS 123
MARKET SIZE 123
TABLE 78 GLOBAL SALES OF ANTIFUNGAL PROPHYLAXIS IN LIVER TRANSPLANTS, BY REGION, THROUGH 2014 ($ MILLIONS) 124
FIGURE 44 GLOBAL SALES OF ANTIFUNGAL PROPHYLAXIS IN LIVER TRANSPLANTS, BY REGION, 2007-2014 ($ MILLIONS) 124
GALLSTONE SOLUBILIZING AGENTS 124
MARKET SIZE 125
TABLE 79 GLOBAL SALES OF GALLSTONE SOLUBILIZING AGENTS, BY REGION, THROUGH 2014 ($ MILLIONS) 125
FIG
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |